Obsessive-Compulsive Disorder Market To Reach US$ 1,050 Million By 2033, at CAGR Of 5% From 2023 to 2033, IMARC Group

The newly published report by IMARC Group, titled "Obsessive-Compulsive Disorder Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033″, presents a comprehensive analysis of the obsessive-compulsive disorder market. The report provides an overview of the market trends, growth prospects, investment opportunities, and industry prospects, as well as an analysis of the disease overview, market scenario, and growth trends. In addition, the report offers competitor analysis, regional analysis, and recent advancements in the seven major markets (7MM). The report also highlights key segments and market drivers, as well as challenges faced by industry players.

How big is the market for obsessive-compulsive disorder market?

According to IMARC Group, in 2022, the total value of the seven major markets (7MM) for obsessive-compulsive disorder market amounted to US$ 613.2 Million. Looking forward, these markets are anticipated to reach US$ 1,050 Million by 2033, at a growth rate (CAGR) of 5% from 2023-2033.

What is diffuse Obsessive-Compulsive Disorder?

Obsessive-compulsive disorder (OCD) represents a mental health condition characterized by intrusive, recurrent thoughts (obsessions) and repetitive, ritualistic behaviors or mental acts that patients feel compelled to perform. This disease causes significant distress and can interfere with daily functioning, relationships, and the overall quality of life. The common symptoms of the ailment include symmetry or exactness, counting or tapping rituals, fear of losing control, a sense of guilt or shame, aggression, intense stress, concerns about order, anxiety, agitation, etc. OCD is typically diagnosed through a combination of clinical evaluation, assessment of indications, and neurological tests.

Request a Free Sample Report: https://www.imarcgroup.com/obsessive-compulsive-disorder-market/requestsample

What are the key drivers and trends in the Obsessive-Compulsive Disorder Market?

The elevating prevalence of imbalances in specific neurotransmitters, including glutamate, serotonin, dopamine, etc., that can lead to abnormalities in brain structure and functioning is primarily augmenting the obsessive-compulsive disorder market. Additionally, the rising incidences of various associated risk factors, such as certain neurological conditions, chronic stress, traumatic events, genetic mutations, etc., are further stimulating the market growth. Besides this, the emerging popularity of selective serotonin reuptake inhibitors (SSRIs), including fluoxetine and sertraline, which work by inhibiting neurochemical reuptake and providing symptom relief among patients, is acting as another significant growth-inducing factor.

Furthermore, the widespread adoption of habit reversal training procedures that help individuals suffering from OCD regain a sense of control over their thoughts and actions is also contributing to the market growth. Besides this, the elevating utilization of dialectical behavior therapy, as it combines cognitive-behavioral techniques with mindfulness and emotional regulation strategies to improve distress tolerance and minimize compulsiveness in patients, is projected to fuel the obsessive-compulsive disorder market in the coming years.

What is included in the report segmentation?
The report covers the following aspects:

Report Period:

Base Year: 2022
Historical Period: 2017-2022
Market Forecast: 2023-2033

Countries Included:

United States
Germany
France
United Kingdom
Italy
Spain
Japan

Analysis Covered Across Each Country

Historical, current, and future epidemiology scenario
Historical, current, and future performance of the obsessive-compulsive disorder market
Historical, current, and future performance of various therapeutic categories in the market
Sales of various drugs across the obsessive-compulsive disorder market
Reimbursement scenario in the market
In-market and pipeline drugs
In-Market Drugs

Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Drug Uptake and Market Performance

Late-Stage Pipeline Drugs

Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Regulatory Status

Ask an Analyst for Report Customization with TOC & List of figures: https://www.imarcgroup.com/request?type=report&id=7997&flag=C

Browse the Latest Research Report :

Alopecia Areata Market Report: https://www.imarcgroup.com/alopecia-areata-market

Bullous Pemphigoid Market Report: https://www.imarcgroup.com/bullous-pemphigoid-market

Lipodystrophy Market Report: https://www.imarcgroup.com/lipodystrophy-market

Homocystinuria Market Report: https://www.imarcgroup.com/homocystinuria-market

Key Questions Answered in this Report

How has the obsessive-compulsive disorder market performed so far and how will it perform in the coming years?
What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
What was the country-wise size of the obsessive-compulsive disorder market across the seven major markets in 2022 and what will it look like in 2033?
What is the growth rate of the obsessive-compulsive disorder market across the seven major markets and what will be the expected growth over the next ten years?
What are the key unmet needs in the market?

Contact US

IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us: -

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.